Evidence map›Paper›PMID 41367788›Full record

ArticleQuantitative imaging in medicine and surgery2025

Fully automated intensity-modulated radiotherapy plans for rectal cancer based on deep learning predictions of three-dimensional dose distributions.

Yimei Liu, Lin Huang, Zixuan Leng, Meining Chen, Jun Zhang, Ruotong Chen, Zhaocai Chen, Yaoying Liu, Zhenyu Qi, Qichao Zhou and 2 more

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yimei Liu *Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Lin Huang *Department of Oncology, Chaozhou Central Hospital, Chaozhou, China.
Zixuan Leng *Manteia Technologies Co., Ltd., Xiamen, China.
Meining ChenDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Jun ZhangDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Ruotong ChenDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Zhaocai ChenManteia Technologies Co., Ltd., Xiamen, China.
Yaoying LiuManteia Technologies Co., Ltd., Xiamen, China.
Zhenyu QiDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Qichao ZhouManteia Technologies Co., Ltd., Xiamen, China.
Xiaowu DengDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Yinglin PengDepartment of Radiation Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Designing intensity-modulated radiotherapy (IMRT) plans for rectal cancer is complex and time-consuming. We used a three-dimensional (3D) multitask training U-Net (3D MT-U-Net) deep learning (DL) model to accurately predict radiotherapy dose distributions for rectal cancer. We aimed to achieve fully automated IMRT plans with improved efficiency and quality. Methods: We developed a 3D MT-U-Net model that precisely captured dose distribution characteristics through pretraining and a multitask learning mechanism. In the multitask learning module, we additionally introduced the learning of gradient maps and isodose line maps to enhance the network's ability to extract semantic information from dose distributions. The patients were divided into a training set (n=99), an independent test set (n=26), and an external test set (n=15). The high-precision dose predictions were translated into automated optimization objectives by integrating clinical constraints to establish two fully automated optimization methods based on 3D voxel dose and dose-volume histogram (DVH) parameters. The Monte Carlo algorithm was used to perform dose calculations and achieve fully automated plans. Using manually designed plans as a reference, the dose distributions predicted by the model and generated by the automated plans were evaluated using the mean absolute error (MAE) and DVH parameters. Results: Compared with the state-of-the-art DL architectures [pix2pix, DoseDiff (distance-aware diffusion model), and MD-Dose (diffusion model based on the Mamba)], the 3D MT-U-Net model demonstrated substantially improved prediction accuracy respectively, with notable reductions in MAE values for planning target volume (PTV)1 (0.016±0.023 Conclusions: This study developed a fully automated IMRT plan design method for rectal cancer. This approach significantly improved the efficiency of designing IMRT plans and plan quality.

Indexed as

automated planningdeep learning (DL)dose predictionintensity-modulated radiotherapy (IMRT)Rectal cancer

Identifiers

PMID41367788
PMCPMC12682532

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.